WallStreetZenWallStreetZen

NASDAQ: MCRB
Seres Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MCRB

Based on 3 analysts offering 12 month price targets for Seres Therapeutics Inc.
Min Forecast
$7.00+168.2%
Avg Forecast
$9.67+270.38%
Max Forecast
$12.00+359.77%

Should I buy or sell MCRB stock?

Based on 3 analysts offering ratings for Seres Therapeutics Inc.
Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MCRB stock forecasts and price targets.

MCRB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Oppenheimer
Bottom 11%
11
BuyAssumes$12.00+359.77%2023-06-26
Chardan Capital
Top 9%
92
Strong BuyMaintains$10.00+283.14%2023-04-28
JP Morgan
Bottom 4%
4
HoldInitiates Coverage On$7.00+168.20%2023-04-21

1 of 1

Forecast return on equity

Is MCRB forecast to generate an efficient return?
Company
N/A
Industry
0.91%
Market
28.82%

Forecast return on assets

Is MCRB forecast to generate an efficient return on assets?
Company
N/A
Industry
0.07%

MCRB revenue growth forecast

How is MCRB forecast to perform vs Biotechnology companies and vs the US market?
Company
-0.16%
Industry
35.95%
Market
8.15%
MCRB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MCRB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MCRB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MCRB$2.61$9.67+270.38%Buy
MRNS$6.60$21.63+227.65%Strong Buy
VYGR$7.60$16.00+110.53%Strong Buy
ARQT$5.38$42.43+688.64%Strong Buy
QURE$7.09$41.00+478.28%Strong Buy
View Top Biotech Stocks

Seres Therapeutics Stock Forecast FAQ

Is Seres Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: MCRB) stock is to Buy MCRB stock.

Out of 3 analysts, 1 (33.33%) are recommending MCRB as a Strong Buy, 1 (33.33%) are recommending MCRB as a Buy, 1 (33.33%) are recommending MCRB as a Hold, 0 (0%) are recommending MCRB as a Sell, and 0 (0%) are recommending MCRB as a Strong Sell.

If you're new to stock investing, here's how to buy Seres Therapeutics stock.

What is MCRB's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: MCRB) forecast ROE is N/A, which is considered weak.

What is MCRB's Price Target?

According to 3 Wall Street analysts that have issued a 1 year MCRB price target, the average MCRB price target is $9.67, with the highest MCRB stock price forecast at $12.00 and the lowest MCRB stock price forecast at $7.00.

On average, Wall Street analysts predict that Seres Therapeutics's share price could reach $9.67 by Jun 26, 2024. The average Seres Therapeutics stock price prediction forecasts a potential upside of 270.38% from the current MCRB share price of $2.61.

What is MCRB's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: MCRB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.07%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.